lutetium has been researched along with Adenocarcinoma Of Kidney in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boerman, OC; Bos, DL; Mulders, PF; Muselaers, CH; Oosterwijk, E; Oyen, WJ | 1 |
| Boerman, OC; Boers-Sonderen, MJ; Desar, IM; Langenhuijsen, JF; Mulder, SF; Mulders, PF; Muselaers, CH; Oosterwijk, E; Oyen, WJ; Stillebroer, AB; van Herpen, CM; van Oostenbrugge, TJ | 1 |
| Agarwal, N; Pal, SK | 1 |
| Boerman, OC; Mulders, PF; O'Donoghue, JA; Oosterwijk, E; Oyen, WJ; Stillebroer, AB; Visser, EP; Zegers, CM | 1 |
| Boerman, OC; Boers-Sonderen, MJ; Desar, IM; Langenhuijsen, JF; Mulders, PF; Oosterwijk, E; Oyen, WJ; Smith-Jones, PM; Stillebroer, AB; van Herpen, CM | 1 |
| Boerman, OC; Brouwers, AH; Corstens, FH; Frielink, C; Oosterwijk, E; Oyen, WJ; van Eerd, JE | 1 |
1 review(s) available for lutetium and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Kidney cancer: Finding a niche for girentuximab in metastatic renal cell carcinoma.
Topics: Animals; Antibodies, Monoclonal; Carbonic Anhydrase IX; Carcinoma, Renal Cell; Clinical Trials, Phase II as Topic; Humans; Kidney Neoplasms; Lutetium; Radioisotopes | 2016 |
3 trial(s) available for lutetium and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Carbonic Anhydrase IX; Carcinoma, Renal Cell; Disease-Free Survival; Humans; Kidney Neoplasms; Lutetium; Neutropenia; Non-Randomized Controlled Trials as Topic; Radioimmunotherapy; Radioisotopes; Retreatment; Thrombocytopenia | 2016 |
Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging.
Topics: Adult; Aged; Antibodies, Monoclonal; Beta Particles; Bone Marrow; Carcinoma, Renal Cell; Female; Humans; Indium Radioisotopes; Kidney Neoplasms; Lutetium; Male; Middle Aged; Radiation Dosage; Radioimmunotherapy; Radiometry; Radionuclide Imaging; Radiotherapy Dosage | 2012 |
Phase 1 radioimmunotherapy study with lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Renal Cell; Disease Progression; Dose-Response Relationship, Radiation; Female; Humans; Immunoconjugates; Kidney Neoplasms; Lutetium; Male; Maximum Tolerated Dose; Middle Aged; Netherlands; Radioimmunotherapy; Radionuclide Imaging; Radiopharmaceuticals; Time Factors; Tissue Distribution; Treatment Outcome; Tumor Burden; Whole Body Imaging | 2013 |
2 other study(ies) available for lutetium and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Optimizing lutetium 177-anti-carbonic anhydrase IX radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Renal Cell; Cell Line, Tumor; Coordination Complexes; Dose-Response Relationship, Radiation; Heterocyclic Compounds, 1-Ring; Heterografts; Humans; Immunoconjugates; Injections, Intraperitoneal; Kidney Neoplasms; Lutetium; Maximum Tolerated Dose; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Tissue Distribution | 2014 |
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Renal Cell; Humans; Iodine Radioisotopes; Isotope Labeling; Kidney Neoplasms; Lutetium; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution; Yttrium Radioisotopes | 2004 |